Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2022-11-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
北京市康达律师事务所关于新乡拓新药业股份有限公司2022年第六次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of the 2022 sixth extraordinary general meeting (临时股东大会) of Xinxiang Tuoxin Pharmaceutical Co., Ltd. It details the legality of the meeting's call, the qualifications of attendees, the voting process, and the voting results. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. It is not a report of the meeting itself (like AGM materials) but a legal opinion on the meeting's procedural compliance. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural filing related to a shareholder meeting, not the meeting materials or voting results announcement themselves.
2022-11-28 Chinese
2022年第六次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2022 sixth extraordinary general meeting of shareholders of the company. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official announcement of the voting results from the shareholders' meeting. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2088 characters) and it is not a report publication announcement or regulatory filing. Therefore, the classification is DVA with high confidence.
2022-11-28 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using part of its idle raised funds for cash management. It details the investment products purchased, risk analysis, risk control measures, and impact on daily operations. The document is relatively short (1926 characters) and focuses on a specific financing activity related to the use of idle raised funds. It does not contain financial statements or comprehensive financial data, nor is it a full report. It is an update on capital management activities, which fits the category of Capital/Financing Update (CAP).
2022-11-22 Chinese
关于持股5%以上股东通过大宗交易减持公司股份累计超过1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a shareholder holding more than 5% of shares reducing their stake by over 1% through block trades. It includes detailed information about the shareholder, the number of shares reduced, the method of reduction, and compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2022-11-21 Chinese
关于持股5%以上股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, the number of shares released from pledge, and the status of pledged shares. The document is a formal disclosure about shareholding and pledge status, not a financial report, management change, or voting result. It fits the category of Major Shareholding Notification, which covers notifications of changes in significant share ownership or related shareholding matters such as pledges.
2022-11-21 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the use of idle raised funds for cash management, detailing the amounts, investment products, risk analysis, and control measures. It is a progress update on the use of fundraising proceeds rather than a full financial report or audit. The document length is short (2084 characters) and it does not contain financial statements or comprehensive financial data. It is not a report itself but an announcement about the company's financing activities and fund management. Therefore, it fits best under Capital/Financing Update (CAP).
2022-11-17 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.